Clinical Trial Update: Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluated CP-751,871 with paclitaxel and carboplatin in advanced non-small cell lung cancer; the trial has been completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CP-751,871 (dalotuzumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-04-24